Lyme Aware

Potential Lyme Disease Vaccine Shows Promise

A vaccine for Lyme disease may be on its way, following a promising phase 1/2 clinical trial from investigators at the Stony Brook University School of Medicine and Brookhaven National Laboratory. The finding was published online in The Lancet Infectious Diseases, and revealed that the vaccine resulted in significant antibodies against all targeted species of Borrelia – the agent that causes Lyme disease in the United States and Europe. Read more.